Indications And Dose
Chronic hepatitis B (initiated by a specialist) ▶BY MOUTH ▶Adult: 25 mg once daily (for duration of treatment consult product literature)
PDF page 681
Loading InternPractice…
Drug reference
Chronic hepatitis B (initiated by a specialist) ▶BY MOUTH ▶Adult: 25 mg once daily (for duration of treatment consult product literature)
PDF page 681
Decompensated liver disease. HIV co-infection
PDF page 681
Manufacturer advises HIV antibody testing should be offered to those with unknown HIV-1 status before initiation of treatment.
PDF page 681
→Appendix 1: tenofovir alafenamide
PDF page 681
▶Common or very common Abdominal distension. arthralgia . flatulence ▶Frequency not known Hepatitis aggravated (during or following treatment). nephrotoxicity
PDF page 681
Manufacturer advises avoid—present in milk in animal studies.
PDF page 681
Manufacturer advises caution in Infection decompensated hepatic disease (no information available).
PDF page 681
Manufacturer advises monitor liver function tests at repeated intervals during treatment and for at least 6 months after last dose— recurrent hepatitis may occur on discontinuation.
PDF page 681
There can be variation in the licensing of different medicines containing the same drug. Tablet CAUTIONARY AND ADVISORY LABELS 21 ▶Vemlidy (Gilead Sciences International Ltd) A Tenofovir alafenamide (as Tenofovir alafenamide fumarate) 25 mg Vemlidy 25mg tablets | 30 tablet P £325.73 ANTIVIRALS › NUCLEOTIDE ANALOGUES
PDF page 681
Missed doses Manufacturer advises if a dose is more than 18 hours late, the missed dose should not be taken and the next dose should be taken at the normal time.
PDF page 681
25 mg once daily (for duration of treatment
First-line fragment. Read the complete Indications and Dose section above.
PDF page 681